SCHEMBL22037067

SCHEMBL22037067

CCC1CCN(C(C)(C)C)CC1CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24397739 0.84 ATM (0.35) —
SCHEMBL17465657 0.83 — —
SCHEMBL25530700 0.83 — —
SCHEMBL25530694 0.83 — —
SCHEMBL25530702 0.83 — —
SCHEMBL28771452 0.82 CHRNB2 (0.39) —
SCHEMBL21899175 0.82 — —
SCHEMBL12492345 0.82 DPP4 (0.35) —
SCHEMBL21899169 0.82 GBA1 (0.33) —
SCHEMBL29156969 0.82 HTT (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11542248-B2 Methods and compositions for inhibiting the interaction of menin with MLL proteins KURA ONCOLOGY, INC. (US) 2023-01-03 — — US disclosed
US-20200165224-A1 METHODS AND COMPOSITIONS FOR INHIBITING THE INTERACTION OF MENIN WITH MLL PROTEINS WELLSPRING BIOSCIENCES LLC 2020-05-28 — — US disclosed
Send feedback